Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: Three years of blinded therapy followed by one year of open therapy

The American Journal of Medicine

Volumn 95, Issue 6, 1993, Pages 557-567

  Harris, Steven T ^a   Watts, Nelson B ^b   Jackson, Rebecca D ^c   Genant, Harry K ^a   Wasnich, Richard D ^d   Ross, Philip ^d   Miller, Paul D ^e   Licata, Angelo A ^f   Chesnut III, Charles H ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d Hawaii Osteoporosis Center   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; ETIDRONIC ACID; PHOSPHATE; PLACEBO;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FEMUR; HUMAN; LEG CRAMP; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPINE; VERTEBRA FRACTURE;

ANALYSIS OF VARIANCE; BONE DENSITY; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ETIDRONIC ACID; FEMALE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; RESEARCH DESIGN; SPINAL FRACTURES;

EID: 0027738472     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(93)90350-X     Document Type: Article

References (26)

1. Local and systemic factors in the pathogenesis of osteoporosis
2. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen
3. Long-term estrogen replacement therapy prevents bone loss and fractures
4. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer
5. Long-term treatment of established osteoporosis with intranasal calcitonin
6. Bisphosphonates—history and experimental basis
7. The treatment of osteoporosis with disodium ethane-1-hydroxy-1,1-diphosphonate
8. Etidronate disodium in postmenopausal osteoporosis
9. Preliminary observations of a form of coherence therapy for osteoporosis
10. The effect of etidronate therapy in postmenopausal osteoporotic women: preliminary results
11. Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study
12. Effects of cyclical therapy for osteoporosis using an oral regimen of inorganic phosphate and sodium etidronate: a clinical and bone histomorphometric study
13. Cyclic therapy of osteoporosis with neutral phosphate and brief, high-dose pulses of etidronate
14. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis
15. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis
16. The effects of etidronate therapy in postmenopausal osteoporotic women: preliminary results
17. Etidronate cyclical therapy prevents new vertebral fractures in postmenopausal osteoporosis
18. Pre-existing fractures and bone mass predict vertebral fracture incidence in women
19. Epidemiology of fractures
20. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis
21. The effects of etidronate on trabecular bone remodeling in postmenopausal spinal osteoporosis: a randomized study comparing intermittent treatment and an ADFR regime
22. Effects of etidronate and phosphate on bone histomorphometry in women with postmenopausal osteoporosis
23. A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis
24. Evidence for bone remodeling but lack of calcium mobilization response to parathyroid hormone in pseudohypoparathyroidism
25. Diminished rates of bone formation in normal black adults
26. Histomorphometric evaluation of bone biopsies after long-term cyclical etidronate treatment